Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung Cancer

The burden of somatic mutations and neoantigens has been associated with improved survival in cancer treated with immunotherapies, especially non-small cell lung cancer (NSCLC). However, there is uncertainty about their effect on outcome in early-stage untreated cases. We posited that the burden of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dennis, Pham, Nhu-An, Freeman, Timothy M., Raghavan, Vibha, Navab, Roya, Chang, Jonathan, Zhu, Chang-Qi, Ly, Dalam, Tong, Jiefei, Wouters, Bradly G., Pintilie, Melania, Moran, Michael F., Liu, Geoffrey, Shepherd, Frances A., Tsao, Ming-Sound
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678704/
https://www.ncbi.nlm.nih.gov/pubmed/31330989
http://dx.doi.org/10.3390/cancers11071009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678704/
https://www.ncbi.nlm.nih.gov/pubmed/31330989
http://dx.doi.org/10.3390/cancers11071009

Ejemplares similares